MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
156.64%
Quick Ratio
156.64%
Cash Ratio
139.96%
Debt to Asset Ratio
106.36%
Unit: Dollar
Assets Breakdown
Cash and cash equivalents, end o...
Restricted cash, noncurrent
Operating lease, right-of-use as...
Deferred financing costs
Liabilities Breakdown
Accumulated deficit
Common stock, value, issued
Secured long-term debt, noncurre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents, end of year
15,174,128
6,365,624
8,705,218
8,662,091
Prepaid expense, current
1,807,461
916,956
1,086,121
1,119,321
Deferred financing costs
0
0
99,305
-
Total current assets
16,981,589
7,282,580
9,890,644
9,781,412
Restricted cash, noncurrent
10,017,412
-
-
-
Operating lease, right-of-use asset
117,184
144,331
170,733
196,249
Assets
27,116,185
7,426,911
10,061,377
9,977,661
Accounts payable, current
6,734,310
2,278,619
3,435,297
2,027,509
Accrued and other accounts payable
308,007
1,038,731
995,290
1,560,430
Represents the related party payable
161,846
147,223
116,476
143,080
Operating lease, liability, current
137,330
145,456
145,456
141,070
Net balance as at december 31, 2025
-
2,343,778
5,245,543
6,785,812
Secured debt, current
3,500,000
-
-
-
Liabilities, current
10,841,493
5,953,807
9,938,062
10,657,901
Secured long-term debt, noncurrent
17,982,542
-
-
-
Loans payable, noncurrent
17,114
21,042
25,865
29,462
Operating lease, liability, noncurrent
0
24,168
60,139
95,188
Total liabilities
28,841,149
5,999,017
10,024,066
10,782,551
Common stock, value, issued
74,298,513
67,114,012
57,076,175
4
Represents the amount of common shares to be issued
0
313,934
313,934
313,934
Additional paid-in capital
8,884,707
7,478,881
6,879,575
6,449,863
Accumulated other comprehensive income (loss), net of tax
61,095
-190,510
10,880
10,676
Accumulated deficit
-85,007,966
-73,390,261
-64,348,118
-5
Equity, attributable to parent
-1,763,651
1,326,056
-67,554
-910,126
Equity, attributable to noncontrolling interest
38,687
101,838
104,865
105,236
Ending balance
-1,724,964
1,427,894
37,311
-804,890
Total liabilities and shareholders' deficit
27,116,185
7,426,911
10,061,377
9,977,661
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents, end of year
$15,174,128
(56.93%↑ Y/Y)
Prepaid expense,
current
$1,807,461
(36.19%↑ Y/Y)
Total current assets
$16,981,589
(54.42%↑ Y/Y)
Restricted cash,
noncurrent
$10,017,412
Operating lease,
right-of-use asset
$117,184
(-46.98%↓ Y/Y)
Accumulated deficit
-$85,007,966
(-111.56%↓ Y/Y)
Assets
$27,116,185
(127.21%↑ Y/Y)
Equity, attributable to
parent
-$1,763,651
Common stock, value,
issued
$74,298,513
(96.38%↑ Y/Y)
Additional paid-in capital
$8,884,707
(58.74%↑ Y/Y)
Accumulated other
comprehensive income (loss),...
$61,095
Total liabilities and
shareholders' deficit
$27,116,185
(127.21%↑ Y/Y)
Ending balance
-$1,724,964
(-153.10%↓ Y/Y)
Equity, attributable to
noncontrolling interest
$38,687
Total liabilities
$28,841,149
(232.04%↑ Y/Y)
Secured long-term debt,
noncurrent
$17,982,542
Liabilities, current
$10,841,493
(26.89%↑ Y/Y)
Loans payable,
noncurrent
$17,114
Accounts payable,
current
$6,734,310
(280.43%↑ Y/Y)
Secured debt, current
$3,500,000
Accrued and other
accounts payable
$308,007
(-83.15%↓ Y/Y)
Represents the related
party payable
$161,846
(33.46%↑ Y/Y)
Operating lease,
liability, current
$137,330
(10.39%↑ Y/Y)
Buy us a coffee
Medicus Pharma Ltd. (MDCXW)
Medicus Pharma Ltd. (MDCXW)